FLT3 and myeloid neoplasm: Current research results indicate that FLT3-ITD may lead to unfavourable impact on the prognosis especially a high relapse rate in patients with myeloid neoplasm, while the impact of FLT3-TKD on the prognosis is still unclear [23].